CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZN

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
AZNPhase 3

eculizumab Phase 3 Est. Readout

Eculizumab
Dec 2026~STALE
CT.gov
00%
Competitive Landscape

0 competitors in Atypical Hemolytic Uremic Syndrome

View Full Landscape
Drug Information

Target Indication

Atypical Hemolytic Uremic Syndrome

Clinical Trial

NCT00844844

Last updated: 4/29/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.